AstraZeneca PLC (ZEGA) — Long-term Investment Intensity
AstraZeneca PLC (ZEGA) has a Long-term Investment Intensity of 2.5% as of December 2019. Long-term investments of €1.51 Billion represent 2.5% of total assets of €61.38 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ZEGA book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AstraZeneca PLC Long-term Investment Intensity (2014–2019)
This chart shows how AstraZeneca PLC's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 2.5%, reflecting long-term investments of €1.51 Billion against total assets of €61.38 Billion EUR. Also explore balance sheet size of AstraZeneca PLC for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for AstraZeneca PLC (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for AstraZeneca PLC from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AstraZeneca PLC market capitalisation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.5% | €1.51 Billion | €61.38 Billion | ▲ +0.9 pp |
| 2018 | 1.6% | €978.00 Million | €60.65 Billion | ▼ -0.2 pp |
| 2017 | 1.8% | €1.12 Billion | €63.35 Billion | ▲ +0.3 pp |
| 2016 | 1.4% | €891.00 Million | €62.53 Billion | ▲ +0.3 pp |
| 2015 | 1.1% | €669.00 Million | €60.06 Billion | ▼ -0.1 pp |
| 2014 | 1.2% | €722.00 Million | €58.59 Billion | — |